ADJUVANT THERAPY
Clinical trials for ADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo tested to stop throat cancer return
Disease control Not yet recruitingThis study tests whether a new drug, Becotatug vedotin, works better than the standard drug capecitabine to prevent cancer from coming back in people with advanced nasopharyngeal carcinoma. About 218 adults who have already completed initial chemo-radiation will be randomly assig…
Matched conditions: ADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated May 26, 2026 11:27 UTC
-
New drug cocktail aims to stop cervical cancer recurrence after surgery
Disease control Not yet recruitingThis study tests whether combining two drugs, camrelizumab and famitinib, can help prevent cervical cancer from coming back after surgery. About 30 women with specific cancer types and stages will receive this treatment for up to two years. The main goal is to see how many remain…
Matched conditions: ADJUVANT THERAPY
Phase: NA • Sponsor: Jin LI • Aim: Disease control
Last updated May 26, 2026 11:25 UTC
-
AI-Guided immunotherapy aims to stop liver cancer recurrence
Disease control Not yet recruitingThis study tests whether a deep learning model can identify which liver cancer patients benefit from immunotherapy (PD-1 inhibitors) after surgery to prevent the cancer from returning. About 300 adults who had their liver cancer completely removed will be followed to see if the A…
Matched conditions: ADJUVANT THERAPY
Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC